IL13 and Alzheimer disease: Additional susceptibility loci identified included OVOL1 (epidermal differentiation) and KIF3A (epithelial barrier function), IL13 (type 2 cytokine signaling), and TNFRSF6B (apoptosis regulation), highlighting the complex polygenic architecture shaping the barrier, immune, and apoptotic pathways implicated in AD susceptibility [21].